Page last updated: 2024-11-05

thiotepa and Carcinoma, Basal Cell, Pigmented

thiotepa has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vollebergh, MA1
Lips, EH1
Nederlof, PM1
Wessels, LFA1
Schmidt, MK1
van Beers, EH1
Cornelissen, S1
Holtkamp, M1
Froklage, FE1
de Vries, EGE1
Schrama, JG1
Wesseling, J1
van de Vijver, MJ1
van Tinteren, H1
de Bruin, M1
Hauptmann, M1
Rodenhuis, S1
Linn, SC1
Moskalik, KG1
Kozlov, AP1
Akimov, AA1

Reviews

1 review available for thiotepa and Carcinoma, Basal Cell, Pigmented

ArticleYear
[Use of optical quantum generators (lasers) in oncology].
    Voprosy onkologii, 1972, Volume: 18, Issue:8

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom

1972

Trials

1 trial available for thiotepa and Carcinoma, Basal Cell, Pigmented

ArticleYear
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Carboplatin;

2011